We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




PET Imaging Method Found Effective for Accurate Diagnosis of Gall Bladder Cancer

By HospiMedica International staff writers
Posted on 08 Nov 2010
Researchers found that a metabolic imaging diagnosis technique based on the analysis of a structural analog of glucose labeled with a positron-emitting compound (18F) allows for the early diagnosis of gall bladder cancer, a relatively rare disease with high mortality rates among most patients suffering from it.

For the purpose of this study, 62 patients were subjected to this scanning method, which represents the largest sample of patients with gall bladder cancer ever studied by applying a technology called fluorodeoxyglucose (FDG) positron emission tomography (PET). More...
The study's researchers, from the University of Granada (UGR; Spain) and the department of nuclear medicine, Hospital Virgen de las Nieves at Granada, reported results considerably better than other structural imaging methods that enabled more accurate and appropriate diagnosis and treatment of patients, which avoids unnecessary procedures.

This study was conducted by Dr. Carlos Ramos Font and directed by Prof. Nicolás Olea Serrano (UGR), Prof. José Manuel Llamas Elvira (UGR, department of nuclear medicine, Hospital Virgen de las Nieves), and Prof. Manuel Gómez Río (department of nuclear medicine, Hospital Virgen de las Nieves).

The high mortality rate among patients with gall bladder cancer depends greatly on the lack of clinical data enabling early diagnosis of this type of tumors. This fact determines the survival of this type of patients. At the moment of establishing a diagnosis, an accurate staging will allow to choose the most appropriate treatment, as well as to optimize the use of the resources available. Imaging diagnosis of this pathology is essentially based on morphologic techniques (ultrasound, computed tomography [CT], and magnetic resonance imaging [MRI]).

This new imaging diagnosis method (tomography made by emission of positrons with 18F-FDG) shows glucose metabolism in tissues. While the utility of this method has been validated in other types of tumors, its utility in gall bladder cancer had not been proven yet.

According to Granada University researchers, their study demonstrated PET scanning with FDG "is a valid and accurate method for precise staging of patients with suspected gall bladder cancer, which allows to determine the appropriate therapy and treatment, and to optimize the use of the resources available.” Therefore, the researchers suggest, "each patient with suspected cancer should be subjected to this type of imaging diagnosis, to determine the nature of such process.”

Related Links:

University of Granada


New
Gold Member
Breast Imaging Monitor
Barco Coronis Onelook MDMC-32133 32MP
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Medical-Grade Display
HL2316SHTB
New
Gold Member
Radiology Monitor
MDNC-12130 Barco Nio Fusion 12MP
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image Cedit: Shutterstock

New Light-Activated Platform Advances Glioblastoma Surgery and Postoperative Treatment

Glioblastoma, an aggressive primary brain tumor, infiltrates healthy tissue and resists complete surgical removal. Residual microscopic disease and the blood–brain barrier limit the effectiveness of adjuvant... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.